Trial Profile
Evaluation of the Sensitivity of Pharmacokinetics to Differences in the Particle Size Distribution of Two Different Formulations of a Locally-acting Mometasone Furoate Suspension-based Nasal Spray
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Sep 2023
Price :
$35
*
At a glance
- Drugs Mometasone (Primary)
- Indications Allergic rhinitis; Asthma; Nasal polyps; Perennial allergic rhinitis; Seasonal allergic rhinitis; Sinusitis; Skin disorders
- Focus Pharmacokinetics
- 15 Nov 2021 Status changed from active, no longer recruiting to completed.
- 03 Sep 2020 Planned End Date changed from 1 Dec 2020 to 1 Aug 2021.
- 20 Jul 2020 Planned End Date changed from 1 Jul 2020 to 1 Dec 2020.